Publicaciones en colaboración con investigadores/as de Hospital de Sant Pau i Santa Tecla (4)

2012

  1. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial

    The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246

2011

  1. Brief report: Phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors

    Oncology, Vol. 80, Núm. 3-4, pp. 219-222

2009

  1. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

    European Journal of Cancer, Vol. 45, Núm. 5, pp. 732-735

2005

  1. Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours

    Annals of Oncology, Vol. 16, Núm. 12, pp. 1915-1920